Altru Telehealth, LLC dba Altru Telehealth
FDA issued a warning letter to Altru Telehealth, LLC (dba Altru Telehealth) on June 8, 2026, following a March 2026 review of its website, which marketed compounded semaglutide and tirzepatide products. The agency found that Altru's website made false or misleading claims by implying the compounded products were FDA-approved and that its compounding pharmacies held FDA approval or licensure — designations that do not legally exist for compounding facilities. These representations caused the compounded drug products to be misbranded under sections 502(a) and 502(bb) of the FD&C Act, constituting prohibited acts under section 301(a). FDA demanded a written corrective response within 15 business days and warned that failure to comply could result in seizure or injunction.
Flagged claims (5)
Compounded semaglutide combines the FDA approved active ingredient semaglutide with a body safe vitamin such as B12.
An FDA approved, regulated & sterile compounding pharmacy mixes the formula based on the medical providers [sic] prescription
Our compounding pharmacies are all FDA approved....
Semaglutide & Tirzepatide is the active ingredient used in FDA-Approved weekly injection Wegovy® and Mounjaro….
Compounded semaglutide & tirzepatide offers the same results but at a fraction of the cost of brand names such as Ozempic, Mounjaro & Wegovy.
Required actions (4)
Send your written response to the Office of Compounding Quality and Compliance (OCQC) within the Center for Drug Evaluation and Research (CDER)'s Office of Compliance at [email protected] within fifteen (15) business days of receipt of this letter.
Addressing other website claims that contain false or misleading representations about your compounded drug products or demonstrating that such claims have been modified or removed in light of FD&C Act §§ 502(a) and 502(bb) [21 U.S.C. §§ 352(a) and 352(bb)].
Identifying the entities that produce the compounded drug products offered on your website;
Providing a representative sample of labeling for such drug products;
Does your site contain similar claims?
The free site audit scans your whole site against every entry in this Atlas. Most pharmacy / compounding sites match 3-6 patterns.
Run my free site auditWorried about one specific page, ad, or email? Paste it into the free Claim Checker and see what the FDA and FTC would flag, with the precedent next to each one. No email required.
Check specific copy in the Claim Checker